Should docetaxel be standard of care for patients with metastatic hormone-sensitive prostate cancer? Pro and contraPotential increased risk of cancer from commonly used medications: an umbrella review of meta-analysesEfficacy of carboplatin-taxane combinations in the management of castration-resistant prostate cancer: a pooled analysis of seven prospective clinical trialsThe epithelial-mesenchymal transition (EMT) phenomenonEuropean Guidelines for Quality Assurance in Cervical Cancer Screening. Second edition--summary documentPrevalence of undertreatment in cancer pain. A review of published literatureThresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009Crizotinib resistance: implications for therapeutic strategiesThe role of the ALK receptor in cancer biologyCrizotinib: from discovery to accelerated development to front-line treatmentALK evaluation in the world of multiplex testing: Network Genomic Medicine (NGM): the Cologne model for implementing personalised oncologyPrecision medicine in NSCLC and pathology: how does ALK fit in the pathway?The forgotten woman's cancer: vulvar squamous cell carcinoma (VSCC) and a targeted approach to therapySequential pathogenesis of metastatic VHL mutant clear cell renal cell carcinoma: putting it together with a translational perspectiveThe promise of immunotherapy in head and neck squamous cell carcinomaCervical esophageal cancer: a gap in cancer knowledgeFactors affecting uptake and adherence to breast cancer chemoprevention: a systematic review and meta-analysisWaldenström's macroglobulinemia: a clinical perspective in the era of novel therapeuticsShort- and long-term benefits of lenalidomide treatment in patients with lower-risk del(5q) myelodysplastic syndromesStatistical controversies in clinical research: long-term follow-up of clinical trials in cancerMuscle dysfunction in cancer patientsState of the art of surgery in advanced epithelial ovarian cancerBreast cancer risk in BRCA1 mutation carriers: insight from mouse modelsSorafenib: from literature to clinical practiceMaternal and fetal outcomes of taxane chemotherapy in breast and ovarian cancer during pregnancy: case series and review of the literatureAlcohol and liver cancer: a systematic review and meta-analysis of prospective studiesPostprogression survival for first-line chemotherapy of patients with advanced non-small-cell lung cancerThe contribution of molecular epidemiology to the identification of human carcinogens: current status and future perspectivesThe current and future impact of human papillomavirus on treatment of squamous cell carcinoma of the head and neckFactors influencing adherence to cancer treatment in older adults with cancer: a systematic reviewTargeting triple-negative breast cancer: optimising therapeutic outcomesConcurrent systemic therapy with radiotherapy for the treatment of poor-risk patients with unresectable stage III non-small-cell lung cancer: a review of the literatureDietary patterns and gastric cancer risk: a systematic review and meta-analysisClinical biomarkers of response in advanced renal cell carcinomaOrigin and molecular pathogenesis of ovarian high-grade serous carcinomaThe impact of the process of clinical research on health service outcomesIntegrating bevacizumab into the management of epithelial ovarian cancer: the controversy of front-line versus recurrent diseaseA critical review of the analytical approaches for circulating tumor biomarker kinetics during treatmentImaging bone metastases in breast cancer: evidence on comparative test accuracyPersonalizing, not patronizing: the case for patient autonomy by unbiased presentation of management options in stage I testicular cancer
P1433
Q24289204-F0C5C332-D318-4F82-AF0E-592C24EAD5E4Q24289205-26CDDCBF-1D67-43A6-A67A-C1D8E0047650Q24599547-7B58468A-3FCD-44A3-9970-A1F3E55E9C71Q24600898-0605564A-625C-4E43-88D4-1803607C8B50Q24644710-CE637606-F846-4EEE-BCAC-0DDA94D377E7Q24646347-E3011C7D-8AC6-4DB5-B808-ABEEB0A5B358Q24657145-15F5A33A-470F-43B0-A9AD-104F4BCFE0E8Q26738381-20302E1E-353D-428F-8C80-17F73E53123DQ26738384-0E0CB97D-811F-43B5-B43D-B1839B8EC6C6Q26738385-4F0D71F8-315C-4594-B10C-D45600DD6627Q26738387-CFC8300C-C4BE-4779-A0A9-42AF3EF05BEBQ26738390-327A4BA1-5149-438A-B213-8F3D4D3E0F87Q26744087-E0033172-6086-4854-A3F6-084492DA8DA7Q26744089-4C77620C-18F4-4AAD-9AD6-F00CD743C5F7Q26744433-6AB7809F-9916-4080-9497-461A4FD75447Q26749536-477D1DCF-FB09-4B7B-9905-BE2B40CB1EA0Q26773464-5ECBD138-9E4D-46A4-8528-CA839A14649EQ26776391-EB25F58E-BB68-482B-8F35-278A2DA35CAAQ26778754-F902CD42-AA71-4775-9352-B44D681A4A46Q26782494-123E3E6E-C5B3-4BDD-8719-524ECE3EC2E5Q26822365-2C97B853-E872-448C-BFE6-CCEDA6BD2550Q26822788-13E2FC0A-A13B-4AD9-873D-08AF0C8735B2Q26823062-65DFF288-57A7-47AE-ABFE-2B6232BD6125Q26826933-FCA7C9F9-2FE8-4757-A99E-F6AFCE2A4C40Q26827698-863AFCD7-3E9E-475C-9270-8811B7F03009Q26828925-0F7BFD95-9DBE-4F9F-BD05-D5068CBD9DC0Q26829939-88711D58-15D6-4D7E-98A6-2A261D94A5E5Q26830046-B4C78487-6579-485B-8953-F9510849F574Q26830495-04A6B3CD-26E9-4D0B-862C-119B431529A8Q26850736-3DDD49E6-6AA8-4973-B5E7-F9002F9ED17EQ26850892-12ADFDD9-DBBE-4E7D-9B65-27CF0EA7AFDCQ26851579-DC0AFCF6-7DC9-4DE3-85AF-17E7360808A7Q26851692-252DA8AB-0949-43C1-AE8A-AF240201711DQ26852564-18F6AEA9-B457-440C-A0B5-09900B2352C7Q26852698-BDDE0210-AC57-4FC2-85E8-FE87E8F4049BQ26858784-438B3BB5-692C-4F72-B255-4E18B8C88964Q26859466-772E9739-C542-4EA1-AADD-84FF4FBA414AQ26862558-2884E175-5AF4-4AE7-A16D-6F3817E72298Q26862731-3F21C231-AFE1-4060-B1E9-20F0D2ADDFBBQ26865075-6E13AD57-3892-4E9E-93B9-6D3E817CD9A8
P1433
description
begutachtete wissenschaftliche Zeitschrift
@de
peer-reviewed scientific journal
@en
revista científica
@es
revue scientifique
@fr
rivista scientifica
@it
videnskabeligt tidsskrift
@da
vědecký časopis
@cs
wetenschappelijk tijdschrift van Oxford University Press
@nl
рецензований науковий журнал
@uk
वैज्ञानिक पत्रिका
@hi
name
Annals of Oncology
@ast
Annals of Oncology
@da
Annals of Oncology
@de
Annals of Oncology
@en
Annals of Oncology
@es
Annals of Oncology
@et
Annals of Oncology
@fi
Annals of Oncology
@fo
Annals of Oncology
@fr
Annals of Oncology
@is
type
label
Annals of Oncology
@ast
Annals of Oncology
@da
Annals of Oncology
@de
Annals of Oncology
@en
Annals of Oncology
@es
Annals of Oncology
@et
Annals of Oncology
@fi
Annals of Oncology
@fo
Annals of Oncology
@fr
Annals of Oncology
@is
prefLabel
Annals of Oncology
@ast
Annals of Oncology
@da
Annals of Oncology
@de
Annals of Oncology
@en
Annals of Oncology
@es
Annals of Oncology
@et
Annals of Oncology
@fi
Annals of Oncology
@fo
Annals of Oncology
@fr
Annals of Oncology
@is
P243
P3181
P4616
P1055
P1058
P1156
P1159
P1160
Ann. Oncol.
P1277
P1476
Annals of Oncology
@en
P236
P243
P407
P5396
annalsoncology
P571
1990-01-01T00:00:00Z